These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 9008612)

  • 1. Degradation of type II collagen, but not proteoglycan, correlates with matrix metalloproteinase activity in cartilage explant cultures.
    Kozaci LD; Buttle DJ; Hollander AP
    Arthritis Rheum; 1997 Jan; 40(1):164-74. PubMed ID: 9008612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinoic acid-induced type II collagen degradation does not correlate with matrix metalloproteinase activity in cartilage explant cultures.
    Price JS; Wang-Weigand S; Bohne R; Kozaci LD; Hollander AP
    Arthritis Rheum; 1999 Jan; 42(1):137-47. PubMed ID: 9920024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase.
    Billinghurst RC; Wu W; Ionescu M; Reiner A; Dahlberg L; Chen J; van Wart H; Poole AR
    Arthritis Rheum; 2000 Mar; 43(3):664-72. PubMed ID: 10728761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromelysin 1, neutrophil collagenase, and collagenase 3 do not play major roles in a model of chondrocyte mediated cartilage breakdown.
    Kozaci LD; Brown CJ; Adcocks C; Galloway A; Hollander AP; Buttle DJ
    Mol Pathol; 1998 Oct; 51(5):282-6. PubMed ID: 10193524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of furin-like enzymes blocks interleukin-1alpha/oncostatin M-stimulated cartilage degradation.
    Milner JM; Rowan AD; Elliott SF; Cawston TE
    Arthritis Rheum; 2003 Apr; 48(4):1057-66. PubMed ID: 12687549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of growth factors and interleukin-1 alpha on proteoglycan and type II collagen turnover in bovine nasal and articular chondrocyte pellet cultures.
    Xu C; Oyajobi BO; Frazer A; Kozaci LD; Russell RG; Hollander AP
    Endocrinology; 1996 Aug; 137(8):3557-65. PubMed ID: 8754787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of bovine nasal cartilage degradation by selective matrix metalloproteinase inhibitors.
    Bottomley KM; Borkakoti N; Bradshaw D; Brown PA; Broadhurst MJ; Budd JM; Elliott L; Eyers P; Hallam TJ; Handa BK; Hill CH; James M; Lahm HW; Lawton G; Merritt JE; Nixon JS; Röthlisberger U; Whittle A; Johnson WH
    Biochem J; 1997 Apr; 323 ( Pt 2)(Pt 2):483-8. PubMed ID: 9163342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1).
    Dahlberg L; Billinghurst RC; Manner P; Nelson F; Webb G; Ionescu M; Reiner A; Tanzer M; Zukor D; Chen J; van Wart HE; Poole AR
    Arthritis Rheum; 2000 Mar; 43(3):673-82. PubMed ID: 10728762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A fibronectin fragment induces type II collagen degradation by collagenase through an interleukin-1-mediated pathway.
    Yasuda T; Poole AR
    Arthritis Rheum; 2002 Jan; 46(1):138-48. PubMed ID: 11817586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The regulation of MMPs and TIMPs in cartilage turnover.
    Cawston T; Billington C; Cleaver C; Elliott S; Hui W; Koshy P; Shingleton B; Rowan A
    Ann N Y Acad Sci; 1999 Jun; 878():120-9. PubMed ID: 10415724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of stromelysin activity on proteoglycan degradation of canine articular cartilage explants.
    Todhunter RJ; Yeh LA; Sheldon A; Grisanzio L; Walker SL; Burton-Wurster N; Lust G
    Am J Vet Res; 1995 Sep; 56(9):1241-7. PubMed ID: 7486406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance of small leucine-rich repeat proteoglycans to proteolytic degradation during interleukin-1-stimulated cartilage catabolism.
    Sztrolovics R; White RJ; Poole AR; Mort JS; Roughley PJ
    Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):571-7. PubMed ID: 10215595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of procollagenases is a key control point in cartilage collagen degradation: interaction of serine and metalloproteinase pathways.
    Milner JM; Elliott SF; Cawston TE
    Arthritis Rheum; 2001 Sep; 44(9):2084-96. PubMed ID: 11592371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of culture conditions and exposure to catabolic stimulators (IL-1 and retinoic acid) on the expression of matrix metalloproteinases (MMPs) and disintegrin metalloproteinases (ADAMs) by articular cartilage chondrocytes.
    Flannery CR; Little CB; Caterson B; Hughes CE
    Matrix Biol; 1999 Jun; 18(3):225-37. PubMed ID: 10429942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 45 kDa collagen-binding fragment of fibronectin induces matrix metalloproteinase-13 synthesis by chondrocytes and aggrecan degradation by aggrecanases.
    Stanton H; Ung L; Fosang AJ
    Biochem J; 2002 May; 364(Pt 1):181-90. PubMed ID: 11988091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
    Little CB; Flannery CR; Hughes CE; Mort JS; Roughley PJ; Dent C; Caterson B
    Biochem J; 1999 Nov; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix degradation by chondrocytes cultured in alginate: IL-1 beta induces proteoglycan degradation and proMMP synthesis but does not result in collagen degradation.
    Beekman B; Verzijl N; de Roos JA; TeKoppele JM
    Osteoarthritis Cartilage; 1998 Sep; 6(5):330-40. PubMed ID: 10197168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage.
    Kobayashi M; Squires GR; Mousa A; Tanzer M; Zukor DJ; Antoniou J; Feige U; Poole AR
    Arthritis Rheum; 2005 Jan; 52(1):128-35. PubMed ID: 15641080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cartilage proteoglycan release by a specific inactivator of cathepsin B and an inhibitor of matrix metalloproteinases. Evidence for two converging pathways of chondrocyte-mediated proteoglycan degradation.
    Buttle DJ; Handley CJ; Ilic MZ; Saklatvala J; Murata M; Barrett AJ
    Arthritis Rheum; 1993 Dec; 36(12):1709-17. PubMed ID: 8250991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esculetin (dihydroxycoumarin) inhibits the production of matrix metalloproteinases in cartilage explants, and oral administration of its prodrug, CPA-926, suppresses cartilage destruction in rabbit experimental osteoarthritis.
    Yamada H; Watanabe K; Saito T; Hayashi H; Niitani Y; Kikuchi T; Ito A; Fujikawa K; Lohmander LS
    J Rheumatol; 1999 Mar; 26(3):654-62. PubMed ID: 10090178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.